Literature DB >> 26663912

5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.

Coral K Wille1, Dhananjay M Nawandar2, Amanda N Henning3, Shidong Ma3, Kayla M Oetting3, Dennis Lee3, Paul Lambert3, Eric C Johannsen4, Shannon C Kenney5.   

Abstract

Latent Epstein-Barr virus (EBV) infection and cellular hypermethylation are hallmarks of undifferentiated nasopharyngeal carcinoma (NPC). However, EBV infection of normal oral epithelial cells is confined to differentiated cells and is lytic. Here we demonstrate that the EBV genome can become 5-hydroxymethylated and that this DNA modification affects EBV lytic reactivation. We show that global 5-hydroxymethylcytosine (5hmC)-modified DNA accumulates during normal epithelial-cell differentiation, whereas EBV+ NPCs have little if any 5hmC-modified DNA. Furthermore, we find that increasing cellular ten-eleven translocation (TET) activity [which converts methylated cytosine (5mC) to 5hmC] decreases methylation, and increases 5hmC modification, of lytic EBV promoters in EBV-infected cell lines containing highly methylated viral genomes. Conversely, inhibition of endogenous TET activity increases lytic EBV promoter methylation in an EBV-infected telomerase-immortalized normal oral keratinocyte (NOKs) cell line where lytic viral promoters are largely unmethylated. We demonstrate that these cytosine modifications differentially affect the ability of the two EBV immediate-early proteins, BZLF1 (Z) and BRLF1 (R), to induce the lytic form of viral infection. Although methylation of lytic EBV promoters increases Z-mediated and inhibits R-mediated lytic reactivation, 5hmC modification of lytic EBV promoters has the opposite effect. We also identify a specific CpG-containing Z-binding site on the BRLF1 promoter that must be methylated for Z-mediated viral reactivation and show that TET-mediated 5hmC modification of this site in NOKs prevents Z-mediated viral reactivation. Decreased 5-hydroxymethylation of cellular and viral genes may contribute to NPC formation.

Entities:  

Keywords:  5hmC; EBV; NPC; lytic reactivation

Mesh:

Substances:

Year:  2015        PMID: 26663912      PMCID: PMC4703011          DOI: 10.1073/pnas.1513432112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Epstein-Barr virus infection and replication in a human epithelial cell system.

Authors:  Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

3.  The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.

Authors:  Prasanna M Bhende; William T Seaman; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

4.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.

Authors:  R T Sarisky; Z Gao; P M Lieberman; E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

6.  Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.

Authors:  G Niedobitek; L S Young; R Lau; L Brooks; D Greenspan; J S Greenspan; A B Rickinson
Journal:  J Gen Virol       Date:  1991-12       Impact factor: 3.891

7.  Aberrations in the MTS1 tumor suppressor locus in oral squamous cell carcinoma lines preferentially affect the INK4A gene and result in increased cdk6 activity.

Authors:  Siribang-on Piboonniyom; Stefanie Timmermann; Philip Hinds; Karl Münger
Journal:  Oral Oncol       Date:  2002-02       Impact factor: 5.337

8.  The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.

Authors:  Gregory K Hong; Henri-Jacques Delecluse; Henri Gruffat; Thomas E Morrison; Wen-Hai Feng; Alain Sergeant; Shannon C Kenney
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.

Authors:  J M Hardwick; P M Lieberman; S D Hayward
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.

Authors:  L S Young; R Lau; M Rowe; G Niedobitek; G Packham; F Shanahan; D T Rowe; D Greenspan; J S Greenspan; A B Rickinson; P J Farrell
Journal:  J Virol       Date:  1991-06       Impact factor: 6.549

View more
  15 in total

1.  p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer.

Authors:  Piotr T Filipczak; Shuguang Leng; Carmen S Tellez; Kieu C Do; Marcie J Grimes; Cynthia L Thomas; Stephanie R Walton-Filipczak; Maria A Picchi; Steven A Belinsky
Journal:  Cancer Res       Date:  2019-01-08       Impact factor: 12.701

2.  Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus.

Authors:  Fang Lu; Andreas Wiedmer; Kayla A Martin; Priyankara J M S Wickramasinghe; Andrew V Kossenkov; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

3.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

4.  Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.

Authors:  Coral K Wille; Yangguang Li; Lixin Rui; Eric C Johannsen; Shannon C Kenney
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

5.  Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration.

Authors:  Elin Engdahl; Nicky Dunn; Pitt Niehusmann; Sarah Wideman; Peter Wipfler; Albert J Becker; Tomas J Ekström; Malin Almgren; Anna Fogdell-Hahn
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

Review 6.  Epstein-Barr virus: Biology and clinical disease.

Authors:  Blossom Damania; Shannon C Kenney; Nancy Raab-Traub
Journal:  Cell       Date:  2022-09-15       Impact factor: 66.850

Review 7.  Epigenetic control of the Epstein-Barr lifecycle.

Authors:  Rui Guo; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2021-12-08       Impact factor: 7.121

Review 8.  Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

Authors:  Thomas C Frost; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2018-09-15       Impact factor: 7.090

Review 9.  DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations.

Authors:  Mankgopo Magdeline Kgatle; Catherine Wendy Spearman; Asgar Ali Kalla; Henry Norman Hairwadzi
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

10.  Methyl-dependent and spatial-specific DNA recognition by the orthologous transcription factors human AP-1 and Epstein-Barr virus Zta.

Authors:  Samuel Hong; Dongxue Wang; John R Horton; Xing Zhang; Samuel H Speck; Robert M Blumenthal; Xiaodong Cheng
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.